Search results
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 77% of the...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Here's What Merck & Co., Inc.'s (NYSE:MRK) Shareholder Ownership Structure Looks Like
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Merck & Co., Inc. (NYSE:MRK) should be aware of the most powerful shareholder...
Merck & Co. (MRK) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Merck & Co. (NYSE: MRK) Q2 2022 Earnings Call Jul 28, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Merck & Co., Inc.'s (NYSE:MRK) high institutional ownership speaks for itself as stock continues to...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Merck & Co., Inc. (NYSE:MRK), then you'll have to look at...
Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck...
With 77% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, Merck's stock price might be...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 10 hours agoAmong abstracts announced yesterday by the American Society of Clinical Oncology (ASCO) is positive...
Q4 2023 Merck & Co Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Caroline Litchfield; Executive VP & CFO; Merck & Co., Inc. Dean Y. Li; Executive VP & President of Merck Research Laboratories; Merck & Co., Inc. Peter Dannenbaum; VP of IR; Merck ...
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) has agreed to acquire Imago BioSciences Inc (NASDAQ: IMGO) for $36.00 per...
